Opiate receptor antagonist modulates movement disorder

摘要

A method for modulating onset of tardive dyskinesia in a subject includes the step of administering to the subject an opiate receptor antagonist concomitantly with the neuroleptic. Also, a method for modulating a genetic or idiopathic or psychogenic hyperkinetic movement disorder, such as that characteristic of Huntington's Disease, includes the step of administering to the subject an opiate receptor antagonist.